Cargando…
Thyroid autoimmunity and hypothyroidism are associated with deep molecular response in patients with chronic myeloid leukemia on tyrosine kinase inhibitors
PURPOSE: Thyroid alterations including de novo appearance of thyroid autoimmunity are adverse effects of tyrosine kinase inhibitors, used in solid and hematologic cancer therapy, but the relationship between thyroid alterations during this treatment and the outcome of chronic myeloid leukemia remain...
Autores principales: | Rodia, R., Pani, F., Caocci, G., La Nasa, G., Simula, M. P., Mulas, O., Velluzzi, F., Loviselli, A., Mariotti, S., Boi, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783879/ https://www.ncbi.nlm.nih.gov/pubmed/34283388 http://dx.doi.org/10.1007/s40618-021-01613-5 |
Ejemplares similares
-
Arterial Hypertension and Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis
por: Mulas, Olga, et al.
Publicado: (2021) -
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors
por: Caocci, Giovanni, et al.
Publicado: (2020) -
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity
por: Rodia, R., et al.
Publicado: (2022) -
Prognostic Role of Cell Blood Count in Chronic Myeloid Neoplasm and Acute Myeloid Leukemia and Its Possible Implications in Hematopoietic Stem Cell Transplantation
por: Mulas, Olga, et al.
Publicado: (2022) -
Association between High Normal TSH Levels and Obesity in Women with Anti-Thyroid Autoantibodies (ATAs)
por: Velluzzi, Fernanda, et al.
Publicado: (2022)